EIF4EBP1 and breast carcinoma: Furthermore, genes within the amplicon as well as mTORC1, which phosphorylates 4EBP1, have been shown to activate ER, potentially contributing to the ability of amplicon bearing breast cancer cells to circumvent endocrine therapy.